nateglinide

Generic: nateglinide

Labeler: dr. reddy's laboratories limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name nateglinide
Generic Name nateglinide
Labeler dr. reddy's laboratories limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

nateglinide 120 mg/1

Manufacturer
Dr. Reddy's Laboratories Limited

Identifiers & Regulatory

Product NDC 55111-329
Product ID 55111-329_4e11dea8-92ab-762e-9808-fad73bf42330
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077461
Listing Expiration 2026-12-31
Marketing Start 2009-09-09

Pharmacologic Class

Established (EPC)
glinide [epc]
Mechanism of Action
potassium channel antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55111329
Hyphenated Format 55111-329

Supplemental Identifiers

RxCUI
311919 314142
UPC
0355111329909
UNII
41X3PWK4O2
NUI
N0000175428 N0000175448

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nateglinide (source: ndc)
Generic Name nateglinide (source: ndc)
Application Number ANDA077461 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 120 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (55111-329-01)
  • 500 TABLET in 1 BOTTLE (55111-329-05)
  • 30 TABLET in 1 BOTTLE (55111-329-30)
  • 10 BLISTER PACK in 1 CARTON (55111-329-78) / 10 TABLET in 1 BLISTER PACK (55111-329-79)
  • 90 TABLET in 1 BOTTLE (55111-329-90)
source: ndc

Packages (5)

55111-329-01 100 TABLET in 1 BOTTLE (55111-329-01) 55111-329-05 500 TABLET in 1 BOTTLE (55111-329-05) 55111-329-30 30 TABLET in 1 BOTTLE (55111-329-30) 55111-329-78 10 BLISTER PACK in 1 CARTON (55111-329-78) / 10 TABLET in 1 BLISTER PACK (55111-329-79) 55111-329-90 90 TABLET in 1 BOTTLE (55111-329-90)

Ingredients (1)

nateglinide (120 mg/1)

Linked Drug Pages (1)

Nateglinide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4e11dea8-92ab-762e-9808-fad73bf42330", "openfda": {"nui": ["N0000175428", "N0000175448"], "upc": ["0355111329909"], "unii": ["41X3PWK4O2"], "rxcui": ["311919", "314142"], "spl_set_id": ["f7b28951-76d2-cabd-64a1-b74aa225c6e9"], "pharm_class_epc": ["Glinide [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (55111-329-01)", "package_ndc": "55111-329-01", "marketing_start_date": "20090909"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (55111-329-05)", "package_ndc": "55111-329-05", "marketing_start_date": "20090909"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (55111-329-30)", "package_ndc": "55111-329-30", "marketing_start_date": "20090909"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (55111-329-78)  / 10 TABLET in 1 BLISTER PACK (55111-329-79)", "package_ndc": "55111-329-78", "marketing_start_date": "20090909"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (55111-329-90)", "package_ndc": "55111-329-90", "marketing_end_date": "20260630", "marketing_start_date": "20090909"}], "brand_name": "Nateglinide", "product_id": "55111-329_4e11dea8-92ab-762e-9808-fad73bf42330", "dosage_form": "TABLET", "pharm_class": ["Glinide [EPC]", "Potassium Channel Antagonists [MoA]"], "product_ndc": "55111-329", "generic_name": "Nateglinide", "labeler_name": "Dr. Reddy's Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nateglinide", "active_ingredients": [{"name": "NATEGLINIDE", "strength": "120 mg/1"}], "application_number": "ANDA077461", "marketing_category": "ANDA", "marketing_start_date": "20090909", "listing_expiration_date": "20261231"}